Market oscillate’ s around the 6500 region after a tough week
**No weekend report out on Sunday, instead we’ll wrap it up in a Monday Morning note given the market is open despite the public holiday. I have Harry on the desk for the day, I’ll hopefully be celebrating a Canberra win in GF - given Manly were robbed, I’d love to see the green machine get up!! Have a great long weekend all** James
WHAT MATTERED TODAY
After a fairly brutal week across markets with the local index down around 2.5% although today we saw some consolidation around the 6500 region as we suggested was the likely outcome this morning. A low of 6490 and a high of 6532 with the index closing in the upper end the daily range, although only marginally so. While the market has pulled back this week, we’re certainly not seeing a lot of panic set in to stocks, the usual push / pull of weak economic data offset by the high chance of further central bank support dictating the state of play at the moment.
Healthcare stocks were strong today thanks to a 3+% rally in CSL on a Morgan Stanley upgrade, the broker upgrading to buy with a $251 target , the health index up by +2.30% as a consequence while we also saw strong buying the Tech names, Appen (APX) +3.11%, Xero (XRO) +3.16% and Jumbo Interactive +6.07% the standouts. Bingo (BIN) also caught my eye adding +2.31% to $2.18, after a fairly tough week.
To reiterate, our best guess at this stage is we will see a period of consolidation, ideally around the 6500 area, but importantly our preferred scenario is still we see a break by the ASX200 towards 6300. Stocks may have kicked off the new quarter in the worst fashion since just after the GFC but MM remains keen to buy only ~3% lower.
Overall, the ASX 200 closed higher today, up 24pts or +0.37% to 6517, Dow Futures are trading down -20pts/-0.08%.
S&P/ ASX 200 Chart
ASX 200 Chart
Sectors this week – All in the red bar healthcare on the week and that was driven by a CSL upgrade today.
Stocks this week
BROKER MOVES;
· ALS Downgraded to Neutral at Goldman; Price Target A$8.40
· CSL Upgraded to Overweight at Morgan Stanley; PT A$251
· FAR Downgraded to Equal-weight at Morgan Stanley
· Growthpoint Rated New Hold at Moelis & Company; PT A$4.24
· Janus Henderson Downgraded to Underperform at KBW; PT $19.50
· NextDC Upgraded to Add at Morgans Financial; Price Target A$6.68
OUR CALLS
No changes today – we’re comfortable with our positioning given the weeks moves, although being comfortable is always an emotion that scares me!
Major Movers Today
Have a great night
James & the Market Matters Team
Disclosure
Market Matters may hold stocks mentioned in this report. Subscribers can view a full list of holdings on the website by clicking here. Positions are updated each Friday, or after the session when positions are traded.
Disclaimer
All figures contained from sources believed to be accurate. All prices stated are based on the last close price at the time of writing unless otherwise noted. Market Matters does not make any representation of warranty as to the accuracy of the figures or prices and disclaims any liability resulting from any inaccuracy.
Reports and other documents published on this website and email (‘Reports’) are authored by Market Matters and the reports represent the views of Market Matters. The Market Matters Report is based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.
The Reports contain general, as opposed to personal, advice. That means they are prepared for multiple distributions without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor. Market Matters or its author(s) accepts no responsibility for any losses or damages resulting from decisions made from or because of information within this publication. Investing and trading in financial products are always risky, so you should do your own research before buying or selling a financial product.
The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports. Market Matters may publish content sourced from external content providers.
If you rely on a Report, you do so at your own risk. Past performance is not an indication of future performance. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.
